Chapter 42 Specific painful neuropathies

Anderson, 2001, Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias, vol. 2., 2991 Apartis, 1996, Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection?, J Neurol Neurosurg Psychiatry, 60, 661, 10.1136/jnnp.60.6.661 Asbury, 1987, Sensory neuronopathy, Semin Neurol, 7, 58, 10.1055/s-2008-1041406 Assmann, 2001, Familial analphalipoproteinemia: Tangier disease, vol. 2., 2937 Barohn, 1993, Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals, Arch Neurol, 50, 167, 10.1001/archneur.1993.00540020045016 Beck, 2004, Fabry disease: overall effects of agalsidase alfa treatment, Eur J Clin Invest, 34, 838, 10.1111/j.1365-2362.2004.01424.x Behse, 1977, Alcoholic neuropathy: clinical, electrophysiological, and biopsy findings, Ann Neurol, 2, 95, 10.1002/ana.410020203 Bejaoui, 2001, SPTLC1 is mutated in hereditary sensory neuropathy, type 1, Nat Genet, 27, 261, 10.1038/85817 Bennett, 1991, The role of the sympathetic nervous system in painful peripheral neuropathy, Pain, 45, 221, 10.1016/0304-3959(91)90045-Y Bird, 1991, Corticosteroid-responsive dominantly inherited neuropathy in childhood, Neurol, 41, 437, 10.1212/WNL.41.3.437 Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat Genet, 22, 347, 10.1038/11914 Bradley, 1998, Morphometric analysis of the peripheral neuropathy of AIDS, Muscle Nerve, 21, 1188, 10.1002/(SICI)1097-4598(199809)21:9<1188::AID-MUS10>3.0.CO;2-O Bressler, 2004, Peripheral neuropathy associated with prolonged use of linezolid, Lancet Infect Dis, 4, 528, 10.1016/S1473-3099(04)01109-0 Brooks-Wilson, 1999, Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nat Genet, 22, 336, 10.1038/11905 Browne, 1993, 2’,3’-didehydro-3’-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial, J Infect Dis, 167, 21, 10.1093/infdis/167.1.21 Chaudhry, 1996, A prospective study of suramin-induced peripheral neuropathy, Brain, 119, 2039, 10.1093/brain/119.6.2039 Collins, 2004, Non-systemic vasculitic neuropathy, Curr Opin Neurol, 17, 587, 10.1097/00019052-200410000-00009 Collins, 2003, Nonsystemic vasculitic neuropathy: insights from a clinical cohort, Neurology, 61, 623, 10.1212/01.WNL.0000082715.48844.3E Cornblath, 1988, Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex, Neurology, 38, 794, 10.1212/WNL.38.5.794 Cornblath, 1987, Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection, Ann Neurol, 21, 32, 10.1002/ana.410210107 Coxon, 1976, Metronidazole neuropathy, J Neurol Neurosurg Psychiatry, 39, 403, 10.1136/jnnp.39.4.403 D’Amour, 1994, Pathogenesis of alcoholic peripheral neuropathy: direct effect of ethanol or nutritional deficit?, Metab Brain Dis, 9, 133, 10.1007/BF01999766 Dalakas, 2001, Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2’3’-dideoxycytidine (ddC), Lab Invest, 81, 1537, 10.1038/labinvest.3780367 Dawkins, 2001, Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I, Nat Genet, 27, 309, 10.1038/85879 Dellagi, 1983, Waldenstrom’s macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients, Blood, 62, 280, 10.1182/blood.V62.2.280.280 Desnick, 2001, α-Galactosidase A deficiency: Fabry disease, vol. 2, 3733 Dubinsky, 1989, Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2’,3’-dideoxycytidine (ddC), Muscle Nerve, 12, 856, 10.1002/mus.880121012 Dyck, 1993, Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons, vol. 2, 1065 Dyck, 1978, Adult onset of Tangier disease: I. Morphometric and pathologic studies suggesting delayed degradation of neutral lipids after fiber degeneration, J Neuropath Exp Neurol, 37, 119, 10.1097/00005072-197803000-00002 Dyck, 1982, Prednisone-responsive hereditary motor and sensory neuropathy, 57, 239 Dyck, 1983, “Burning feet” as the only manifestation of dominantly inherited sensory neuropathy, 58, 426 Dyck, 1987, Nonsystemic vasculitic neuropathy, Brain, 110, 843, 10.1093/brain/110.4.843 Dyck, 1993, Hereditary motor and sensory neuropathies, vol. 2, 1094 Engel, 1967, Neuropathy in Tangier disease. Alpha-lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage, Arch Neurol, 17, 1, 10.1001/archneur.1967.00470250005001 Falk, 1997, The systemic amyloidoses, N Engl J Med, 337, 898, 10.1056/NEJM199709253371306 Fauci, 2001, The vasculitis syndromes, 1956 Feldman, 1979, Peripheral neuropathy in arsenic smelter workers, Neurol, 29, 939, 10.1212/WNL.29.7.939 Fuller, 1990, Axonal a trophy in the painful peripheral neuropathy in AIDS, Acta Neuropathol (Berl), 81, 198, 10.1007/BF00334508 Fullerton, 1961, Neuropathy after intake of thalidomide (Distaval), Br Med J, 2, 855, 10.1136/bmj.2.5256.855 Gardne, 1971, Peripheral neuropathy after disulfiram administration, J Neurol Neurosurg Psychiatry, 34, 253, 10.1136/jnnp.34.3.253 Gertz, 2000, Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL), Bone Marrow Transplant, 26, 963, 10.1038/sj.bmt.1702643 Gherardi, 1985, Peripheral neuropathy in patients treated with almitrine dimesylate, Lancet, 1, 1247, 10.1016/S0140-6736(85)92315-3 Gibbels, 1985, Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy Clinical, biochemical, electrophysiological, and morphological evaluation, includi electron microscopy of nerve, muscle, and skin biopsies, J Neurol, 232:, 283, 10.1007/BF00313867 Ginsberg, 2004, Co-existent hereditary and inflammatory neuropathy, Brain, 127, 193, 10.1093/brain/awh017 Ginsberg, 2005, Neurological rarity: Fabry disease, Pract Neurol, 5, 110, 10.1111/j.1474-7766.2005.t01-1-00275.x Gorson, 1995, Idiopathic distal small fiber neuropathy, Acta Neurol Scand, 92, 376, 10.1111/j.1600-0404.1995.tb00150.x Griffin, 1990, Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren’s syndrome, Ann Neurol, 27, 304, 10.1002/ana.410270313 Hawkins, 1990, Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component, N Engl J Med, 323, 508, 10.1056/NEJM199008233230803 Hoffmann, 2005, Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey), J Med Genet, 42, 247, 10.1136/jmg.2004.025791 Holland, 1997, Intraepidermal nerve fiber density in patients with painful sensory neuropathy, Neurol, 48, 708, 10.1212/WNL.48.3.708 Holland, 1998, Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases, Ann Neurol, 44, 47, 10.1002/ana.410440111 Houlden, 2004, A novel RAB7 mutation associated with ulcero-mutilating neuropathy, Ann Neurol, 56, 586, 10.1002/ana.20281 Jaspan, 1982, Hypoglycemic peripheral neuropathy in association with insulinoma: implication of glucopenia rather than hyperinsulinism. Case report and literature review, Medicine (Baltimore), 61, 33, 10.1097/00005792-198201000-00004 Jebsen, 1967, Natural history of uremic polyneuropathy and effects of dialysis, N Engl J Med, 277, 327, 10.1056/NEJM196708172770702 Joy, 1960, Optic and peripheral neuritis. Probable effect of prolonged chloramphenicol therapy, JAMA, 173, 1731, 10.1001/jama.1960.73020330015014a Kaltreider, 1969, The neuropathy of Sjögren’s syndrome. Trigeminal nerve involvement, Ann Intern Med, 70, 751, 10.7326/0003-4819-70-4-751 Kelleher, 1999, Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine, Clin Ther, 21, 1182, 10.1016/S0149-2918(00)80021-1 Kelly, 1981, The spectrum of peripheral neuropathy in myeloma, Neurology, 31, 24, 10.1212/WNL.31.1.24 Khella, 1995, Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review, Neurol, 45, 407, 10.1212/WNL.45.3.407 Kieburtz, 1992, Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine, J Acquir Immune Defic Syndr, 5, 60 Kieburtz, 1998, A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team, Neurology, 51, 1682, 10.1212/WNL.51.6.1682 Kissel, 2001, Vasculitic neuropathy, 202 Kocen, 1970, Peripheral nerve involvement in Fabry’s disease, Arch Neurol (Chicago), 22, 81, 10.1001/archneur.1970.00480190085014 Kyle, 1997, A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine, N Engl J Med, 336, 1202, 10.1056/NEJM199704243361702 Lipton, 1989, Taxol produces a predominantly sensory neuropathy, Neurology, 39, 368, 10.1212/WNL.39.3.368 Logigian, 1997, Peripheral nervous system Lyme borreliosis, Semin Neurol, 17, 25, 10.1055/s-2008-1040909 Luciano, 2002, Physiological characterization of neuropathy in Fabry’s disease, Muscle Nerve, 26, 622, 10.1002/mus.10236 Marbini, 1985, Tangier disease. A case with sensorimotor distal polyneuropathy and lipid accumulation in striated muscle and vasa nervorum, Acta Neuropathol (Berl), 67, 121, 10.1007/BF00688132 Martini, 2004, Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients, Lancet Neurol, 3, 457, 10.1016/S1474-4422(04)00822-1 Matthews, 1965, Sarcoidosis of the nervous system, J Neurol Neurosurg Psychiatry, 28, 23, 10.1136/jnnp.28.1.23 Mehta, 2004, Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey, Eur J Clin Invest, 34, 236, 10.1111/j.1365-2362.2004.01309.x Melgaard, 1982, Misonidazole neuropathy: a clinical, electrophysiological, and histological study, Ann Neurol, 12, 10, 10.1002/ana.410120103 Mellgren, 1989, Peripheral neuropathy in primary Sjögren’s syndrome, Neurology, 39, 390, 10.1212/WNL.39.3.390 Morgan, 1990, The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency) — investigation of symptomatic and presymptomatic patients, QJM, 75, 491 Moulignier, 1997, Peripheral neuropathy in human immunodeficiency virusinfected patients with the diffuse infiltrative lymphocytosis syndrome, Ann Neurol, 41, 438, 10.1002/ana.410410406 Moulin, 1997, Pain in Guillain-Barré syndrome, Neurology, 48, 328, 10.1212/WNL.48.2.328 Newman, 1997, Sarcoidosis, N Engl J Med, 336, 1224, 10.1056/NEJM199704243361706 Nicholson, 1996, The gene for hereditary sensory neuropathy type I (HSN-I) maps to chromosome 9q22.1–q22.3, Nat Genet, 13, 101, 10.1038/ng0596-101 Ochoa, 1993, The human sensory unit and pain: new concepts, syndromes, and tests, Muscle Nerve, 16, 1009, 10.1002/mus.880161003 Ohnishi, 1974, Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia and posterior columns, Arch Neurol, 31, 120, 10.1001/archneur.1974.00490380068009 Olivarius, 1956, Polyneuropathy due to nitrofurantoin therapy, Ugeskr Laeg, 118, 753 Polydefkis, 2002, Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy, Neurology, 58, 115, 10.1212/WNL.58.1.115 Pomfret, 1998, Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy, Transplantation, 65, 918, 10.1097/00007890-199804150-00010 Rajkumar, 1998, Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy, Am J Med, 104, 232, 10.1016/S0002-9343(98)00037-0 Reimann, 1958, Hereditary sensory radicular neuropathy and other defects in a large family: reinvestigation after twenty years and report of a necropsy, Am J Med, 25, 573, 10.1016/0002-9343(58)90046-9 Ropper, 1984, Pain in Guillain-Barré syndrome, Arch Neurol, 41, 511, 10.1001/archneur.1984.04050170057018 Rust, 1999, Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1, Nat Genet, 22, 352, 10.1038/11921 Sacktor, 2001, HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998, Neurol, 56, 257, 10.1212/WNL.56.2.257 Said, 1978, Perhexiline neuropathy: a clinicopathological study, Ann Neurol, 3, 259, 10.1002/ana.410030313 Said, 2001, Leprous neuropathy, 561 Schiffmann, 2001, Enzyme replacement therapy in Fabry disease: a randomized controlled trial, JAMA, 285, 2743, 10.1001/jama.285.21.2743 Schiffmann, 2003, Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease, Muscle Nerve, 28, 703, 10.1002/mus.10497 Shlay, 1998, Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Re, JAMA, 280, 1590, 10.1001/jama.280.18.1590 Simpson, 2000, A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy, Neurology, 54, 2115, 10.1212/WNL.54.11.2115 So, 1994, Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients, Ann Neurology, 35, 53, 10.1002/ana.410350109 Tatum, 1995, Gabapentin treatment of seizures in acute intermittent porphyria, Neurology, 45, 1216, 10.1212/WNL.45.6.1216 Tefferi, 1994, Acute porphyrias: diagnosis and management, Mayo Clin Proc, 69, 991, 10.1016/S0025-6196(12)61827-8 Tyor, 1995, Unifying hypothesis for the pathogenesis of HIVassociated dementia complex, vacuolar myelopathy, and sensory neuropathy, J Acquir Immune Defic Syndr Hum Retrovirol, 9, 379, 10.1097/00042560-199508000-00008 Verhoeven, 2003, Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy, Am J Hum Genet, 72, 722, 10.1086/367847 Wells, 1967, The natural history of neurosarcoidosis, Proc R Soc Med, 60, 1172 Worth, 1985, Peripheral neuropathy due to long term ingestion of allopurinol, Br Med J, 291, 1688 Zuchner, 2003, A novel nonsense mutation in the ABC1 gene causes a severe syringomyelia-like phenotype of Tangier disease, Brain, 126, 920, 10.1093/brain/awg074